Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Revenue (2019 - 2025)

Bioadaptives' Revenue history spans 7 years, with the latest figure at $10427.0 for Q4 2025.

  • Quarterly results put Revenue at $10427.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $18278.0 (up 44.27% YoY), and the annual figure for FY2025 was $18278.0, up 44.27%.
  • Revenue for Q4 2025 was $10427.0 at Bioadaptives, up from $4632.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $15649.0 in Q3 2023 to a low of $675.0 in Q2 2024.
  • The 5-year median for Revenue is $4518.0 (2021), against an average of $5674.4.
  • The sharpest move saw Revenue crashed 71.14% in 2024, then skyrocketed 376.89% in 2025.
  • Year by year, Revenue stood at $3851.0 in 2021, then grew by 3.45% to $3984.0 in 2022, then soared by 80.75% to $7201.0 in 2023, then tumbled by 90.63% to $675.0 in 2024, then skyrocketed by 1444.74% to $10427.0 in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $10427.0, $4632.0, and $3219.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.